Vertex Pharmaceuticals (VRTX) FCF Margin (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted FCF Margin of 30.39% for Q2 2026, down 29.89% on a QoQ basis from 43.35% in Q1 2026, and down 89.0% year-over-year from 276.28% in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) FCF Margin (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported FCF Margin for 18 years, with the latest figure at 30.39% in Q2 2026.
- On a quarterly basis, FCF Margin fell 89.0% year-over-year to 30.39% in Q2 2026; TTM through Jun 2026 was 30.16%, a 49.0% decrease from a year earlier, with the FY2025 full-year figure at 26.61%, up 3378.0% from the prior year.
- FCF Margin was 30.39% for Q2 2026 at Vertex Pharmaceuticals, down from 43.35% in the prior quarter.
- The five-year high for FCF Margin was 49.47% in Q2 2022, with the low at 144.49% in Q2 2024.
- Average FCF Margin over 5 years is 25.45%, with a median of 37.83% recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: FCF Margin plunged 18760 bps in 2024, then soared 17577 bps in 2025.
- Over 5 years, FCF Margin stood at 45.37% in 2022, then tumbled by 85 bps to 7.01% in 2023, then surged by 141 bps to 16.9% in 2024, then tumbled by 35 bps to 10.93% in 2025, then jumped by 178 bps to 30.39% in 2026.
- The last three FCF Margin figures came in at 30.39% (Q2 2026), 43.35% (Q1 2026), and 10.93% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 23.58% |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 30.39% |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | 23.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.39% |
| Mar 31, 2026 | 43.35% |
| Dec 31, 2025 | 10.93% |
| Sep 30, 2025 | 37.04% |
| Jun 30, 2025 | 31.28% |
| Mar 31, 2025 | 28.09% |
| Dec 31, 2024 | 16.90% |
| Sep 30, 2024 | 46.97% |
| Jun 30, 2024 | -144.49% |
| Mar 31, 2024 | 46.02% |
| Dec 31, 2023 | 7.01% |
| Sep 30, 2023 | 49.44% |
| Jun 30, 2023 | 43.11% |
| Mar 31, 2023 | 36.12% |
| Dec 31, 2022 | 45.37% |
| Sep 30, 2022 | 38.61% |
| Jun 30, 2022 | 49.47% |
| Mar 31, 2022 | 42.56% |
| Dec 31, 2021 | 45.03% |
| Sep 30, 2021 | 44.09% |
API Access
Vertex Pharmaceuticals FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();